During the past decade, Instituto Medico Platense conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 10 clinical trials were completed, i.e. on average, 58.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 8 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto Medico Platense" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "University of Minnesota" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Argentinian Intensive Care Society" with 1 trials sponsored and "Corvus Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Medico Platense" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator, "National Institutes of Health (NIH)" with 3 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator and "International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Medico Platense" are "Covid19" (3 trials), "Influenza" (3 trials), "Influenza A" (2 trials), "Acute Respiratory Infection" (1 trials) and "Arthritis, Juvenile" (1 trials). Many other conditions were trialed in "Instituto Medico Platense" in a lesser frequency.

Most popular intervention types in "Instituto Medico Platense" are "Drug" (16 trials), "Other" (6 trials), "Biological" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Pimodivir 600 mg" (2 trials), "SOC Treatment" (2 trials), "Abatacept" (1 trials) and "Ad26.COV2.S" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Medico Platense" are 22 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Instituto Medico Platense". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Instituto Medico Platense, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Medico Platense, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".